Eloxx Pharmaceuticals Inc

NASDAQ:ELOX   10:21:53 AM EDT
0.75
+0.02 (+3.43%)
Earnings Announcements

Eloxx Pharmaceuticals Reports Q3 Loss Of 11 Cents Per Share

Published: 11/09/2021 13:40 GMT
Eloxx Pharmaceuticals Inc (ELOX) - Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update.
Eloxx Pharmaceuticals Inc - As of September 30, 2021, We Had Cash and Cash Equivalents of $52.4 Million.
Eloxx Pharmaceuticals Inc - Expect Cash and Cash Equivalents Will Be Sufficient to Fund Our Operations Into Q1 of 2023.
Eloxx Pharmaceuticals Inc - Qtrly Loss per Share $0.11.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.